Lmr Partners LLP Compass Therapeutics, Inc. Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.64 - $3.48 $172,869 - $227,873	-65,481 Reduced 44.8%	80,692 $256,000
Q1 2023 May 15, 2023	BUY	$3.14 - $5.48 $66,674 - $116,362	21,234 Added 17.0%	146,173 $477,000
Q4 2022 Feb 14, 2023	BUY	$2.55 - $5.41 $63,594 - $134,919	24,939 Added 24.94%	124,939 $628,000
Q4 2021 Feb 14, 2022	BUY	$2.88 - $3.98 $288,000 - $398,000	100,000 New	100,000 $317,000

91.9M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $139M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.